Elisabeth G.E. de Vries
Papers
1
Total Citations
21
H-Index
1
About
Elisabeth G.E. de Vries is a pioneering oncologist whose research has fundamentally advanced the understanding and treatment of neuroendocrine tumors (NETs) through molecular imaging. Her key research areas include nuclear medicine, radiochemistry, and cancer metabolism, with a particular focus on developing PET tracers that visualize the unique metabolic activity of NETs. Her most notable contribution is the development of a reliable, remote-controlled synthesis of β-[¹¹C]-5-hydroxy-L-tryptophan (5-HTP) on a Zymark robotic system, a breakthrough that enabled precise staging of NETs by targeting their serotonin production pathway. This work, published in 2006, has garnered 21 citations and laid the groundwork for comparing 5-HTP PET with other tracers like [¹⁸F]FDOPA. By creating a reproducible method for producing this carbon-11 labeled tracer, de Vries provided clinicians with a powerful tool for detecting and monitoring NETs, directly impacting patient management. Her achievements exemplify how radiochemistry innovation can translate into tangible clinical benefits, making her a respected figure in the field of cancer imaging and a key contributor to the evolution of personalized oncology.
Research Focus
Key Achievements
Top Papers
- 1